A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate A Phase 3 Study of Abataceptin Chinese Patients With Active Rheumatoid Arthritis and Inadequate Resp ...
A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Abatacept 125mg Administered Subcutaneously in Chinese Subjects With Active Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effica ...